Advanced, automated technologies provide high-quality, cGMP-compliant products with minimal human intervention and no hoods.
We are an FDA-registered 503B outsourcing facility that
uses advanced automated technologies to provide
high-quality cGMP-compliant products with minimal
human intervention and no hoods.
Our platform makes ordering simple and secure. Keep your focus on the patients, minimize admin time.
REQUEST ACCESS TODAY!
Our aseptic manufacturing process uses advanced automation in the compounding, sterilizing, filling and sealing of finished product. Blow-fill-seal (BFS) and other automated technologies produce sterile products, and help reduce the chance of contamination.
Every SterRx® product meets cGMP-level standard release testing requirements.
All finished compounded drug batches are tested for sterility, endotoxin, pH, appearance and potency prior to release.
Highly advanced, technological equipment is everywhere: drugs are compounded, filled and sealed in our sterile, automated environment. These processes offer consistent, high-quality product with a reduced risk of contamination, superior production speed and capacity.
A consistent product manufactured with minimal human interaction
can help reduce the risk of contamination and human error.
Other compounded products may use beyond-use dating. We use a more precise statement of product viability: expiration dating. Our customers receive a precise expiration date via our in-house stability testing that includes product testing in real time.
Contact SterRx® at 1-844-319-7799 or email customerservice@SterRx.com
to learn how ready-to-use 503B-compounded products can benefit your facility